|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 41 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-25 |
4 |
B |
$1.60 |
$3,025 |
I/I |
1,892 |
161,997 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-05-25 |
4 |
B |
$11.95 |
$64,722 |
I/I |
5,416 |
11,119,820 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-05-25 |
4 |
B |
$11.95 |
$1,793 |
I/I |
150 |
238,716 |
2.17 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-26 |
4 |
B |
$1.59 |
$102,196 |
I/I |
64,420 |
5,849,271 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-26 |
4 |
B |
$1.59 |
$2,821 |
I/I |
1,778 |
163,775 |
1.42 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-27 |
4 |
B |
$1.60 |
$71,640 |
I/I |
44,862 |
5,894,133 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-27 |
4 |
B |
$1.60 |
$1,977 |
I/I |
1,238 |
165,013 |
1.42 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-28 |
4 |
B |
$1.56 |
$23,798 |
I/I |
14,868 |
179,881 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-28 |
4 |
B |
$1.56 |
$862,159 |
I/I |
538,649 |
6,432,782 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-06-01 |
4 |
B |
$1.58 |
$18,446 |
I/I |
11,252 |
191,133 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-06-01 |
4 |
B |
$1.58 |
$668,272 |
I/I |
407,639 |
6,840,421 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-07 |
4 |
B |
$11.87 |
$36,899 |
I/I |
3,105 |
241,821 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-07 |
4 |
B |
$11.87 |
$1,336,938 |
I/I |
112,500 |
11,232,320 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-08 |
4 |
B |
$11.92 |
$160,502 |
I/I |
13,431 |
255,252 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-06-08 |
4 |
B |
$11.92 |
$5,814,557 |
I/I |
486,569 |
11,718,889 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-06 |
4 |
B |
$14.16 |
$636,250 |
I/I |
44,927 |
4,345,671 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-06 |
4 |
B |
$14.16 |
$17,561 |
I/I |
1,240 |
117,929 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-09 |
4 |
B |
$14.80 |
$927,144 |
I/I |
62,610 |
4,408,281 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-09 |
4 |
B |
$14.80 |
$25,589 |
I/I |
1,728 |
119,657 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$139,654 |
I/I |
(9,916) |
272,438 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$4,416,947 |
I/I |
(313,622) |
8,616,083 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$1,724,784 |
I/I |
(122,467) |
3,364,533 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$140,710 |
I/I |
(9,991) |
274,458 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$93,938 |
I/I |
(6,670) |
183,239 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-10 |
4 |
B |
$14.66 |
$836,217 |
I/I |
56,705 |
4,464,986 |
2.25 |
- |
|
1397 Records found
|
|
Page 41 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|